Lung Cancer News and Research

Latest Lung Cancer News and Research

ALCMI and Scancell collaborate to advance cancer vaccine clinical trials in NSCLC patients

ALCMI and Scancell collaborate to advance cancer vaccine clinical trials in NSCLC patients

GUMC researchers describe lab technique to fill gaps in clinical care and research

GUMC researchers describe lab technique to fill gaps in clinical care and research

Antibodies can activate nerve cells within milliseconds, study shows

Antibodies can activate nerve cells within milliseconds, study shows

Globe-trotting pollutants can last longer and travel much farther than previously predicted

Globe-trotting pollutants can last longer and travel much farther than previously predicted

Dartmouth study examines impact of health insurance status on cancer care

Dartmouth study examines impact of health insurance status on cancer care

Study suggests best sequence of therapies for brain metastases in EGFR mutant lung cancer patients

Study suggests best sequence of therapies for brain metastases in EGFR mutant lung cancer patients

Lung cancer patients who experience anxiety and depression more likely to die sooner, study reveals

Lung cancer patients who experience anxiety and depression more likely to die sooner, study reveals

New drugs that target neighbour proteins may help halt cancer progression

New drugs that target neighbour proteins may help halt cancer progression

STS releases first publicly accessible report of outcomes from lung cancer surgery

STS releases first publicly accessible report of outcomes from lung cancer surgery

Study provides scientific insight into metastatic patterns of EGFR mutated NSCLCs

Study provides scientific insight into metastatic patterns of EGFR mutated NSCLCs

Mayo Clinic researchers identify genetic promoter that drives lung cancer formation

Mayo Clinic researchers identify genetic promoter that drives lung cancer formation

Overall survival of advanced NSCLC patients receiving treatment better than untreated patients

Overall survival of advanced NSCLC patients receiving treatment better than untreated patients

ICLIO white paper spotlights top-level concerns in delivering immunotherapies for cancer

ICLIO white paper spotlights top-level concerns in delivering immunotherapies for cancer

Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

Epigenetic changes drive successful metastases of pancreatic cancer cells

Epigenetic changes drive successful metastases of pancreatic cancer cells

LUNGevity Foundation launches new mobile app to help lung cancer patients manage life

LUNGevity Foundation launches new mobile app to help lung cancer patients manage life

NTNU researchers testing use of new removable stent in the lungs

NTNU researchers testing use of new removable stent in the lungs

Epigenetic modification may be cause of adult throat cancers linked to alcohol, tobacco use

Epigenetic modification may be cause of adult throat cancers linked to alcohol, tobacco use

MUSC scientists design novel antibody-based therapy to fight against cancer

MUSC scientists design novel antibody-based therapy to fight against cancer

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.